Schedule 13G ownership disclosure

Paratek Pharmaceuticals Inc

Security class unavailable · CUSIP: 699374302

Event date: 2020-02-14

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
3.8000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000919574-20-001647
Form type
SC 13G/A
Filer
ARMISTICE CAPITAL, LLC
CIK
CIK 1601086
Filed
Feb 14, 2020
Reporting period
Feb 14, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub